866 Shares in Varian Medical Systems, Inc. (VAR) Purchased by Signaturefd LLC

Signaturefd LLC acquired a new stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) in the first quarter, HoldingsChannel reports. The institutional investor acquired 866 shares of the medical equipment provider’s stock, valued at approximately $106,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. WASHINGTON TRUST Co increased its stake in shares of Varian Medical Systems by 100.0% during the 4th quarter. WASHINGTON TRUST Co now owns 970 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 485 shares during the last quarter. Advisory Services Network LLC increased its stake in shares of Varian Medical Systems by 3,418.8% during the 4th quarter. Advisory Services Network LLC now owns 1,689 shares of the medical equipment provider’s stock valued at $188,000 after acquiring an additional 1,641 shares during the last quarter. MUFG Americas Holdings Corp increased its stake in shares of Varian Medical Systems by 45.2% during the 4th quarter. MUFG Americas Holdings Corp now owns 1,713 shares of the medical equipment provider’s stock valued at $190,000 after acquiring an additional 533 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Varian Medical Systems by 27.7% during the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,968 shares of the medical equipment provider’s stock valued at $218,000 after acquiring an additional 427 shares during the last quarter. Finally, Advisor Partners LLC acquired a new position in shares of Varian Medical Systems during the 4th quarter valued at about $223,000. 94.18% of the stock is owned by institutional investors.

A number of research analysts have recently commented on the stock. Citigroup upped their price objective on shares of Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, January 28th. TheStreet upgraded Varian Medical Systems from a “c” rating to a “b” rating in a report on Wednesday, April 25th. Barrington Research upgraded Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 target price for the company in a report on Thursday, January 25th. Finally, JPMorgan Chase boosted their target price on Varian Medical Systems from $88.00 to $105.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Varian Medical Systems currently has a consensus rating of “Hold” and a consensus price target of $115.13.

In other Varian Medical Systems news, SVP John W. Kuo sold 1,327 shares of the company’s stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $117.15, for a total value of $155,458.05. Following the completion of the transaction, the senior vice president now owns 30,551 shares in the company, valued at approximately $3,579,049.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP John W. Kuo sold 1,328 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $125.51, for a total value of $166,677.28. Following the completion of the transaction, the senior vice president now owns 30,708 shares of the company’s stock, valued at approximately $3,854,161.08. The disclosure for this sale can be found here. In the last 90 days, insiders sold 39,239 shares of company stock valued at $4,696,712. 0.78% of the stock is owned by company insiders.

Shares of NYSE:VAR opened at $118.81 on Wednesday. Varian Medical Systems, Inc. has a 1 year low of $95.23 and a 1 year high of $130.29. The stock has a market cap of $10.83 billion, a PE ratio of 33.00, a PEG ratio of 3.29 and a beta of 0.85.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, April 25th. The medical equipment provider reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.04 by $0.11. The firm had revenue of $729.90 million during the quarter, compared to analysts’ expectations of $685.86 million. Varian Medical Systems had a return on equity of 27.99% and a net margin of 4.77%. Varian Medical Systems’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.89 EPS. research analysts expect that Varian Medical Systems, Inc. will post 4.5 earnings per share for the current fiscal year.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply